190 related articles for article (PubMed ID: 32613874)
21. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
Bhamidimarri KR; Ladino M; Pedraza F; Guerra G; Mattiazzi A; Chen L; Ciancio G; Kupin W; Martin P; Burke G; Roth D
Transpl Int; 2017 Sep; 30(9):865-873. PubMed ID: 28332729
[TBL] [Abstract][Full Text] [Related]
22. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy.
Martínez-Campreciós J; Riveiro-Barciela M; Muñoz-Gómez R; Londoño MC; Roget M; Serra MÁ; Escudero-García D; Purchades L; Rodríguez M; Losa-García JE; Gutiérrez ML; Carmona I; García-Samaniego J; Morano L; Martín-Granizo I; Montero-Alonso M; Prieto M; Delgado M; Ramos N; Azancot MA; Rodríguez-Frías F; Buti M
Gastroenterol Hepatol; 2023 Oct; 46(8):594-602. PubMed ID: 36584754
[TBL] [Abstract][Full Text] [Related]
23. Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals.
Ko SY; Choe WH
Clin Mol Hepatol; 2018 Dec; 24(4):351-357. PubMed ID: 29544240
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C and Treatment in Patients with Chronic Kidney Disease.
Jalota A; Lindner BK; Thomas B; Lerma EV
Dis Mon; 2021 Feb; 67(2):101017. PubMed ID: 32553421
[TBL] [Abstract][Full Text] [Related]
25. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL; ; ; ;
Intern Emerg Med; 2018 Dec; 13(8):1139-1166. PubMed ID: 30255464
[TBL] [Abstract][Full Text] [Related]
26. DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting.
Beinhardt S; Al Zoairy R; Ferenci P; Kozbial K; Freissmuth C; Stern R; Stättermayer AF; Stauber R; Strasser M; Zoller H; Watschinger B; Schmidt A; Trauner M; Hofer H; Maieron A
Transpl Int; 2016 Sep; 29(9):999-1007. PubMed ID: 27203857
[TBL] [Abstract][Full Text] [Related]
27. Managing hepatitis C therapy failures and chronic kidney disease.
Fabrizi F; Messa P
Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1135-1142. PubMed ID: 30309263
[TBL] [Abstract][Full Text] [Related]
28. Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.
Awan AAY; Berenguer MC; Bruchfeld A; Fabrizi F; Goldberg DS; Jia J; Kamar N; Mohamed R; Pessôa MG; Pol S; Sise ME; Balk EM; Gordon CE; Adam G; Cheung M; Earley A; Martin P; Jadoul M
Ann Intern Med; 2023 Dec; 176(12):1648-1655. PubMed ID: 38079642
[TBL] [Abstract][Full Text] [Related]
29. Sofosbuvir Monotherapy for Asymptomatic and Noncirrhotic Hepatitis C Infection in a Renal Retransplantation Recipient: A Case Report.
Deng G; Ma J; Shen S; Li Q; Peng L; Meng S; Zhou J; Wu J; Liu D
Transplant Proc; 2016 Nov; 48(9):3120-3122. PubMed ID: 27932161
[TBL] [Abstract][Full Text] [Related]
30. Treating Hepatitis C in Patients with Renal Failure.
Lens S; Rodriguez-Tajes S; Llovet LP; Maduell F; Londoño MC
Dig Dis; 2017; 35(4):339-346. PubMed ID: 28467997
[TBL] [Abstract][Full Text] [Related]
31. Treatment and management options for the hepatitis C virus infected kidney transplant candidate.
Dejman A; Ladino MA; Roth D
Hemodial Int; 2018 Apr; 22 Suppl 1():S36-S44. PubMed ID: 29694726
[TBL] [Abstract][Full Text] [Related]
32. Acute interstitial nephritis following treatment with direct-acting antiviral agents in hepatitis C virus-infected patients: A case series.
Duque JC; Dejman A; Venkat V; Hernandez M; Roth D; Ladino MA
Clin Nephrol; 2021 Jan; 95(1):22-27. PubMed ID: 32909545
[TBL] [Abstract][Full Text] [Related]
33. Direct-Acting Antiviral Agents for the Hepatitis C Virus-Infected Chronic Kidney Disease Population: The Dawn of a New Era.
Kusnir J; Roth D
Semin Dial; 2016; 29(1):5-6. PubMed ID: 26781743
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function.
Shin HP; Park JA; Burman B; Kozarek RA; Siddique A
Clin Mol Hepatol; 2017 Dec; 23(4):316-322. PubMed ID: 28827512
[TBL] [Abstract][Full Text] [Related]
35. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
[TBL] [Abstract][Full Text] [Related]
36. Chronic Hepatitis C Virus Infection After Kidney Transplantation With or Without Direct-Acting Antivirals in a Real-Life Setting: A French Multicenter Experience.
Chevallier E; Büchler M; Caillard S; Bouvier N; Colosio C; Rivalan J; Sayegh J; Bertrand D; Le Meur Y; Thierry A; Garrouste C; Rerolle JP; Rostaing L; Gatault P
Transplant Proc; 2020 Dec; 52(10):3179-3185. PubMed ID: 32636068
[TBL] [Abstract][Full Text] [Related]
37. Direct acting anti-viral medications for hepatitis C: Clinical trials in patients with advanced chronic kidney disease.
Bruchfeld A; Lindahl K
Semin Dial; 2019 Mar; 32(2):135-140. PubMed ID: 30475421
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
Lin MV; Sise ME; Pavlakis M; Amundsen BM; Chute D; Rutherford AE; Chung RT; Curry MP; Hanifi JM; Gabardi S; Chandraker A; Heher EC; Elias N; Riella LV
PLoS One; 2016; 11(7):e0158431. PubMed ID: 27415632
[TBL] [Abstract][Full Text] [Related]
39. Sofosbuvir-based hepatitis C therapies in patients with chronic and end-stage kidney disease.
Sise ME; McQuaid T; Martin P
Nephrol Dial Transplant; 2022 Nov; 37(12):2327-2334. PubMed ID: 33848334
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C.
Fernández I; Muñoz-Gómez R; Pascasio JM; Baliellas C; Polanco N; Esforzado N; Arias A; Prieto M; Castells L; Cuervas-Mons V; Hernández O; Crespo J; Calleja JL; Forns X; Londoño MC
J Hepatol; 2017 Apr; 66(4):718-723. PubMed ID: 28039098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
